SYSTEMS AND METHODS FOR ANALYZING, INTERPRETING, AND ACTING ON CONTINUOUS GLUCOSE MONITORING DATA
Patent №
US 11,344,232
Granted
2022-05-31
Filed 2021
Owner
WELLDOC, INC.
Lab
—
AI components
4
ml · kr · planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17226629
Methods and devices include automated coaching for management of glucose states by receiving a user's glucose levels using a continuous glucose monitoring (CGM) device, determining a time in range (TIR) value, determining a TIR state, receiving a glucose variability (GV) value, determining a GV state, determining a starting state based on the TIR state and the GV state, determining that the starting state corresponds to a non-ideal state, generating an optimized pathway to reach an ideal state based on one or more account vectors such as addressing self-management behavior including food, activity, and medication use. The optimized pathway may further be based on computer detection and classification of significant events of interest over time.
AI classification
Ownership
WELLDOC, INC.
assignment · 560830911
Assignors
LIU, SHIPING, SHOMALI, MANSUR, KUMBARA, ABHIMANYU, IYER, ANAND, PEEPLES, MALINDA, DUGAS, MICHELLE, CROWLEY, KENYON, GAO, GUODONG
On an employer assignment, the assignors are typically the inventors.